GENE - Genetic Technologies Limited

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 521.5M
Enterprise Value 316.41M
Trailing P/E N/A
Forward P/E 1N/A
PEG Ratio (5 yr expected) 1N/A
Price/Sales (ttm)113.30
Price/Book (mrq)4.20
Enterprise Value/Revenue 386.51
Enterprise Value/EBITDA 6-3.06

Financial Highlights

Currency in AUD.

Fiscal Year

Fiscal Year Ends Jun 30, 2017
Most Recent Quarter (mrq)Dec 31, 2017

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-2,948.98%

Management Effectiveness

Return on Assets (ttm)-36.41%
Return on Equity (ttm)-69.24%

Income Statement

Revenue (ttm)189.72k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)-73.50%
Gross Profit (ttm)26.09k
EBITDA -5.36M
Net Income Avi to Common (ttm)-5.86M
Diluted EPS (ttm)-0.30
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)5.83M
Total Cash Per Share (mrq)0.36
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)6.95
Book Value Per Share (mrq)0.30

Cash Flow Statement

Operating Cash Flow (ttm)-4.85M
Levered Free Cash Flow (ttm)-3.42M

Trading Information

Stock Price History

Beta 4.29
52-Week Change 37.24%
S&P500 52-Week Change 310.29%
52 Week High 32.05
52 Week Low 30.70
50-Day Moving Average 31.25
200-Day Moving Average 31.24

Share Statistics

Avg Vol (3 month) 3109.49k
Avg Vol (10 day) 345.26k
Shares Outstanding 52.44B
Float 11.19M
% Held by Insiders 10.00%
% Held by Institutions 10.00%
Shares Short 3505.18k
Short Ratio 35.17
Short % of Float 30.00%
Shares Short (prior month) 3512.71k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 21/5
Last Split Date 3Jan 20, 2015